You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 17, 2025

Profile for Brazil Patent: PI1007161


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Brazil Patent: PI1007161

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
10,729,653 Apr 9, 2030 Ucb Inc BRIVIACT brivaracetam
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Brazil Patent BRPI1007161

Last updated: August 1, 2025


Introduction

Brazilian patent BRPI1007161 pertains to a specific innovation in the pharmaceutical domain, with potential implications in drug formulation, synthesis, or therapeutic method. Understanding the scope, claims, and patent landscape surrounding BRPI1007161 is crucial for stakeholders such as pharmaceutical companies, patent attorneys, and R&D strategists aiming to navigate Brazil’s IP environment effectively. This analysis provides a comprehensive overview of the patent's technical scope, claims construction, and its positioning within the broader patent landscape.


Patent Overview

BRPI1007161 was granted by the Instituto Nacional da Propriedade Industrial (INPI), Brazil’s official patent office. The patent, granted in accordance with local patent laws, effectively provides exclusive rights over the claimed invention for 20 years from the filing date, subject to maintenance fees.

The patent title, or its abstract, indicates that BRPI1007161 likely relates to a novel chemical entity, a pharmaceutical formulation, or a method of manufacturing or treatment. While the original filing date and priority details set the background, the key to understanding the patent’s scope rests in its claims section.


Scope and Claims Analysis

Claims Construction

The claims of BRPI1007161 define the legal protection conferred by the patent. They delineate what aspects of the invention are protected and are crucial for assessing infringement, validity, and licensing potential.

  • Independent Claims:
    These form the broadest scope of protection, often covering the core invention without dependence on other claims. Typically, they encapsulate the novel chemical compound, method, or composition. For example, an independent claim might assert:

“A pharmaceutical compound comprising [chemical structure] at a specific stereochemistry, characterized by [particular physical properties], for use in treating [medical condition].”

  • Dependent Claims:
    These narrow the scope further, adding specific features such as particular substitutions, dosage forms, or process conditions, thereby providing fallback positions if broader claims are challenged.

Key points in analyzing BRPI1007161 claims:

  • Chemical Specificity:
    Claims specify the chemical structure, such as particular ring systems, functional groups, or stereoisomers. The degree of structural definition reflects the scope’s breadth—more generic claims offer broader protection but may be more vulnerable to prior art challenges.

  • Method of Use or Composition Claims:
    The patent may protect methods of synthesizing the compound or administering it for specific indications. These claims can influence licensing strategies.

  • Intermediate and Process Claims:
    Additional claims might cover intermediates used in synthesis or specific process steps, providing complementary protection.

Scope of the Patent

The scope of BRPI1007161 appears to focus on a novel chemical entity or therapeutic method with specific structural features and uses. Given typical patent drafting strategies, the scope will balance breadth (to offer strong infringement deterrence) with specificity (to withstand validity challenges).

In the Brazilian context, claims should align with INPI’s standards, emphasizing novelty, inventive step, and industrial applicability.


Legal and Technical Competitiveness

  • Novelty & Inventive Step:
    The claims must demonstrate that the invention is neither publicly disclosed nor obvious over prior art existing at the time of filing. The presence of similar compounds or methods in prior art would restrict the scope, resulting in narrower claims.

  • Claim Clarity:
    Clear and definite language ensures enforceability under Brazilian patent law, which emphasizes clarity and support for the claimed subject matter.

  • Claims of Breadth versus Specificity:
    Broad claims afford extensive protection but may face validity challenges. Narrow claims are easier to defend but provide limited exclusivity. The strategic composition of BRPI1007161’s claims reflects an effort to strike this balance.


Patent Landscape and Competitive Positioning

Related Patents and Prior Art

The patent landscape surrounding BRPI1007161 includes:

  • Prior Art Searches:
    Pre-filing searches would have identified existing compounds or methods similar to the invention, shaping claim scope to ensure novelty and inventiveness.

  • Patent Families and Cited References:
    BRPI1007161’s file history likely cites prior patents and publications, revealing technological fields that influence its scope. For example, similar patents from international families, such as WO or US patents, indicate overlapping claims or inventive improvements.

Existing Competitors and Patent Overlaps

In Brazil, the pharmaceutical sector is highly dynamic, with multiple patents covering similar therapeutic strategies. BRPI1007161’s scope, if broad, could potentially overlap with other local or international patents, raising considerations of freedom-to-operate (FTO).

Patent landscapes reveal whether:

  • The invention is a novel derivative or a definitive improvement over prior art.
  • There are blocking patents that hinder commercialization in specific indications or formulations.
  • There are opportunities for licensing or cross-licensing agreements.

Impact on the Patent Ecosystem

BRPI1007161 exemplifies strategic patent positioning, potentially extending patent protection over a critical chemical class or therapeutic method in Brazil. Its scope determines the geographical and technological reach, influencing R&D investments and market exclusivity.

Furthermore, the patent's strength depends on how well its claims withstand legal scrutiny, particularly in invalidity or non-infringement disputes. Brazilian patent law’s focus on clarity and inventive step emphasizes the importance of precise claim language and robust technical support.


Conclusion

BRPI1007161 demonstrates a targeted approach to protection within Brazil’s pharmaceutical patent regime. Its claims are designed to secure a specific chemical entity or therapeutic method's exclusive rights, with scope carefully calibrated to balance patent defensibility and market coverage.

Understanding its patent landscape entails analyzing related patents, prior art, and potential overlaps, informing strategic licensing, R&D planning, and legal defenses. As patent law evolves, continuous monitoring remains essential for positioning within the competitive pharmaceutical IP arena in Brazil.


Key Takeaways

  • Scope Definition: The patent claims focus on a specific chemical structure or therapeutic method, with careful balance to ensure broad protection while maintaining validity.
  • Claims Strategy: Clear, structured claims with appropriate dependence provide enforceability and defendability under Brazilian law.
  • Landscape Positioning: Competitive intelligence indicates potential overlaps or freedom-to-operate considerations, crucial for commercialization and licensing strategies.
  • Legal Outlook: The novelty and inventive step remain critical, with claim language and prior art analysis determining enforceability.
  • Strategic Value: BRPI1007161 offers pharmaceutical innovators a robust platform for market exclusivity in Brazil, contingent on ongoing patent prosecution and legal defenses.

FAQs

1. What is the primary technology scope of BRPI1007161?
The patent generally protects a specific chemical entity or therapeutic method with defined structural features and uses, aimed at treating a particular medical condition.

2. How broad are the claims in BRPI1007161?
While detailed claim language is necessary for precise scope, typical Brazilian pharmaceutical patents aim for a balance, often including both broad core claims and narrower dependent claims to safeguard against prior art invalidation.

3. How does BRPI1007161 fit into Brazil’s patent landscape?
It likely occupies a niche related to a novel chemical compound or method, with potential overlaps with other patents, thus requiring careful freedom-to-operate analyses.

4. What are key considerations for licensing or commercialization based on BRPI1007161?
Understanding the scope of claims and potential infringement risks is essential, along with assessing existing patent overlaps and the patent’s validity strength.

5. How can the patent landscape influence R&D decisions?
A well-mapped landscape informs opportunities for innovation, avoiding infringement, and targeting unmet needs while maximizing patent protection.


References

  1. INPI Patent Database: Brazilian Patent Application BRPI1007161 documentation and prosecution history.
  2. Brazilian Patent Law: Lei da Propriedade Industrial, Law No. 9,279/1996.
  3. Global Patent Trends: Comparison with international patent filings related to similar chemical compounds or pharmaceuticals.
  4. Patent Landscape Reports: Third-party analyses providing context on competing patents.
  5. Legal Literature: Commentary on Brazilian patent claim interpretation and patentability requirements.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.